Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease - ScienceDirect
Kommunfullmäktige - Göteborg
Martha och Albin Löfgrens kulturfond - Stiftelsen för Åbo Akademi
Svenska folkskolans vänner SFV-kalendern Årgång 122
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease - ScienceDirect
A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's Disease - ScienceDirect
Uppleva med munnen - Mun-H-Center
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease - ScienceDirect
Hem - Stiftelsen Konung Gustaf V:s 90-årsfond
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease | Molecular Neurodegeneration | Full Text
Konung Gustaf VI Adolfs fond för svensk kultur | Kungahuset
Så fördelas kulturpengarna i Svenskfinland: Vissa fonder lever kvar i en förgången värld – Kultur och nöje – svenska.yle.fi
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease. - Abstract - Europe PMC
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease. - Abstract - Europe PMC
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease | Molecular Neurodegeneration | Full Text
Märtha och Gustaf Ågrens Stiftelse | Stiftelsemedel.se
Om stiftelsen – Stiftelse till Ingrid och Gustaf Fribergs minne
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease - ScienceDirect
Hem - Stiftelsen Konung Gustaf V:s 90-årsfond
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease. - Abstract - Europe PMC
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease. - Abstract - Europe PMC
Forskning 2012 - Sahlgrenska Universitetssjukhuset
Forskning inom barn- och kvinnosjukvård 2021
PDF) SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
